Informed consent in clinical trials (ICICT) | | | | |
General information (to be completed by interviewer at study coordinating centre) |
1. Name of interviewer: | | | | |
2. Date of interview: | | | | |
3. Department: | | | | |
4. Name of parent study: | | | | |
5. Date of signature of informed consent for parent study: |
6. Duration of follow-up in parent study | / / months | | | |
7. Participation in parent study: | | | | |
| | | | |
| | | | |
8. Could not complete the questionnaire for one of the following reasons: |
| | | | |
| | | | |
| | | | |
| | | | |
Part 1. Patient information (to be completed by interviewer during face-to-face interview with the patient subject) |
9. Primary diagnosis: | | | | |
10. Sex: | | | | |
11. Age: | | | | |
12. Situation: | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
13. Number of children: | | | | |
14. McCabe index: | 1 | 2 | 3 | |
15. Type of illness resulting in inclusion in the parent study: |
| | | | |
| | | | |
16. Prognosis: | | | | |
| | | | |
| | | | |
Person who signed the consent (patient or proxy) (to be completed by interviewer during face-to-face interview with the patient subject) |
17. Understanding of the French language: | | | | |
| | | | |
| | | | |
| | | | |
18. Literacy: | | | | |
| | | | |
| | | | |
| | | | |
Part 2. Parent study (to be completed by interviewer from information obtained at the study coordinating center or from the parent study coordinator) |
18. Type of study (several answers may apply): | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
19. Sponsor: | | | | |
| | | | |
|
| | | | |
| | | | |
20. Preliminary inclusion phase: | | | | |
| | | | |
| | | | |
21. Where is the patient during the most of the parent study: |
| | | | |
| | | | |
| | | | |
| | | | |
22. Participation in the parent study results in additional: |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Part 3. General questions about research protocols (to be completed by interviewer during face-to-face interview with the patient subject) |
23. How would you describe your participation (several answers)? |
| Yes n = 21 (8%) | | | |
| Yes n = 9 (3%) | | | |
| Yes n = 104 (37%) | | | |
| Yes n = 89 (32%) | | | |
| Yes n = 63 (23%) | | | |
24. When you were offered to participate in (parent study) did you understand that you could decide not to participate? |
| n = 265 (95%) | | | |
| n = 14 (5%) | | | |
25. Did you receive this information? | | | | |
| n = 84 (30%) | | | |
| n = 9 (3%) | | | |
| n = 163 (58%) | | | |
| n = 23 (8%) | | | |
26. How was your consent recorded? | | | | |
| n = 57 (20%) | | | |
| n = 10 (4%) | | | |
| n = 212 (76%) | | | |
27. Do you have a copy of your written informed consent form? |
| n = 212 (76%) | | | |
| n = 57 (20%) | | | |
| n = 10 (4%) | | | |
28. Were you given an information document? | | | | |
| n = 104 (37%) | | | |
| n = 163 (58%) | | | |
| n = 12 (4%) | | | |
29. Do you have a copy of this document? | | | | |
| n = 212 (76%) | | | |
| n = 57 (20%) | | | |
| n = 10 (4%) | | | |
30. Who gave you explanations about the parent’s study (several answers possible)? |
| n = 222 (80%) | | | |
| n = 113 (40%) | | | |
| n = 24 (9%) | | | |
| n = 56 (20%) | | | |
31. What was the time interval between receiving information about the disease and the parent study and signature of informed consent forms? |
| | | | |
| n = 83 (30%) | | | |
| n = 36 (13%) | | | |
| n = 144 (52%) | | | |
| n = 16 (6%) | | | |
32. Were you alone with the physician or did a third party assist you? |
| n = 138 (49%) | | | |
| n = 45 (16%) | | | |
| n = 66 (24%) | | | |
| n = 9 (3%) | | | |
| n = 21 (8%) | | | |
33. Were you satisfied by the information received (on parent study)? |
| n = 221 (79%) | | | |
| n = 47 (17%) | | | |
| n = 11 (4%) | | | |
34. I will read a series of statement which can be true or false: |
When you enter a protocol: | | | | |
| True | False | Not sure | |
| 63 (23%) | 203 (73%) | 13 (5%) | |
| 228 (82%) | 34 (12%) | 17 (6%) | |
| 118 (42%) | 142 (51%) | 19 (7%) | |
Suppose that you had decided not to participate (in parent study), do you think that would have made any difference to your usual medical management? |
| n = 36 (13%) | | | |
| n = 243 (87%) | | | |
35. Compared with usual care would you say that participating in a research protocol results for you in (referred to equipoise): |
| n = 31 (11%) | | | |
| n = 145 (52%) | | | |
| n = 58 (22%) | | | |
| n = 45 (16%) | | | |
36. Compared with usual care would you say that participating in a research protocol (referred to equipoise): |
| n = 152 (54%) | | | |
| n = 90 (32%) | | | |
| n = 4 (1%) | | | |
| n = 33 (13%) | | | |
37. I will read a series of statements that may represent reasons to participate in a research protocol. I would like you to tell me whether, for you, these reasons were important, not important, or not relevant. |
| Important | Not important | Not relevant | |
| 249 (89%) | 24 (9%) | 6 (2%) | |
| 222 (80%) | 45 (16%) | 12 (4%) | |
| 193 (69%) | 44 (16%) | 42 (15%) | |
| 161 (58%) | 74 (27%) | 44 (16%) | |
| 149 (53%) | 81 (29%) | 49 (18%) | |
| 98 (35%) | 74 (27%) | 107 (38%) | |
| 67 (24%) | 67 (24%) | 145 (52%) | |
| 60 (22%) | 142 (51%) | 77 (28%) | |
| 12 (4%) | 24 (9%) | 243 (87%) | |
38. Did you receive information? | | | | |
| Orally | Written | Both | Not sure |
| 89 (32%) | 23 (8%) | 91 (33%) | 76 (27%) |
| 101 (36%) | 15 (5%) | 63 (23%) | 100 (36%) |
| 60 (22%) | 24 (9%) | 78 (28%) | 117 (41%) |
| 2 (1%) | 38 (14%) | 9 (3%) | 230 (82%) |
| 74 (27%) | 20 (7%) | 120 (43%) | 65 (23%) |
| 7 (3%) | 57 (20%) | 146 (52%) | |
| 47 (17%) | 18 (7%) | 54 (19%) | 160 (57%) |
| 15 (5%) | 26 (9%) | 16 (6%) | 222 (80%) |
| 9 (3%) | 48 (17%) | 19 (7%) | 203 (73%) |
| 71 (25%) | 42 (15%) | 79 (28%) | 87 (31%) |
| 3 (1%) | 0 | 2 (1%) | 274 (98%) |
39. If you need information or need asking questions about the study protocol, do you think it will be |
| n = 228 (82%) | | | |
| n = 30 (11%) | | | |
| n = 21 (8%) | | | |
QUIZ | | | | |
40. Do you know the word “placebo”? | Yes n = 202 (72%) | | | |
41. Which of the following statements are true or false? |
| True | False | Not sure | |
| 8 (4%) | 178 (88%) | 16 (8%) | |
| 3 (2%) | 184 (91%) | 15 (7%) | |
| 175 (87%) | 12 (6%) | 15 (7%) | |
42. Do you know the word “randomize” or “randomization”? | Yes n = 73 (26%) | | | |
43. Which of the following statements are true or false? |
| True | False | Not sure | |
| 2 (1%) | 52 (19%) | 225 (81%) | |
| 41 (15%) | 11 (4%) | 227 (81%) | |
| 12 (4%) | 40 (14%) | 227 (81%) | |
Part 4. Specific questions (on parent study) | | | | |
44. The main purpose of the study is: | | | | |
| n = 147 (53%) | | | |
| n = 114 (41%) | | | |
| n = 18 (6%) | | | |
45. Who decided on the treatment you received (during parent study)? |
Concerned 147 patients | | | | |
| n = 20 (14%) | | | |
| n = 20 (14%) | | | |
| n = 7 (5%) | | | |
| n = 4 (3%) | | | |
| n = 96 (65%) | | | |
46. Questions about the study medication | | | | |
| Yes n = 122 (83%) | | | |
| Correct n = 130 (88%) | | | |
47. Is it compared to another treatment? | | | | |
| n = 61 (41%) | | | |
| n = 63 (43%) | | | |
| n = 23 (16%) | | | |
48. Do you know which treatment you are taking for this study? |
| n = 29 (20%) | | | |
| n = 32 (22%) | | | |
| n = 86 (59%) | | | |
49. Do you think that your physician knows which medication you are taking? |
| n = 39 (27%) | | | |
| n = 22 (15%) | | | |
| n = 86 (59%) | | | |
If the parent study concerns a diagnostic procedure (concerned 114 patients) |
50. Do you know what the study procedure is? | | | | |
| n = 89 (78%) | | | |
| n = 25 (22%) | | | |
51. Do you know what it is used for? | Yes n = 97 (86%) | | | |
52. Do you know whether this procedure is compared to another? |
| n = 18 (16%) | | | |
| n = 78 (68%) | | | |
| n = 18 (16%) | | | |
To be completed by the interviewer | | | | |
53. Level of patient understanding of the informed consent process |
| n = 232 (83%) | | | |
| n = 47 (17%) | | | |